Search

info:eu-repo/semantics/nonPublished

info:eu-repo/semantics/published

Sulphur dioxide (SO2) fluxes of active degassing volcanoes are routinely measured with ground-based equipment to characterize and monitor volcanic activity. SO2 of unmonitored volcanoes or from explosive volcanic eruptions, can be measured with satellites. However, remote-sensing methods based on absorption spectroscopy generally provide integrated amounts of already dispersed plumes of SO2 and satellite derived flux estimates are rarely reported. Here we review a number of different techniques to derive volcanic SO2 fluxes using satellite measurements of plumes of SO 2 and investigate the temporal evolution of the total emissions of SO2 for three very different volcanic events in 2011: Puyehue-Cordón Caulle (Chile), Nyamulagira (DR Congo) and Nabro (Eritrea). High spectral resolution satellite instruments operating both in the ultraviolet-visible (OMI/Aura and GOME-2/MetOp-A) and thermal infrared (IASI/MetOp-A) spectral ranges, and multispectral satellite instruments operating in the thermal infrared (MODIS/Terra-Aqua) are used. We show that satellite data can provide fluxes with a sampling of a day or less (few hours in the best case). Generally the flux results from the different methods are consistent, and we discuss the advantages and weaknesses of each technique. Although the primary objective of this study is the calculation of SO 2 fluxes, it also enables us to assess the consistency of the SO 2 products from the different sensors used. © 2013 Author(s)., SCOPUS: ar.j, info:eu-repo/semantics/published

info:eu-repo/semantics/nonPublished

International Summer Schools, ISSSE 2006-2008, Contains fulltext : 75746.pdf (publisher's version ) (Closed access)

BACKGROUND: The prognostic role of serum levels of molecular biomarkers during the perioperative period in patients with early breast cancer is not clear. PATIENTS AND METHODS: Serum VEGF and extracellular domains (ECD) of EGFR and HER2 were prospectively determined in 119 consecutive patients with early breast cancer on the day before and after surgery. RESULTS: After a median follow-up of 93 months, the preoperative value and the absolute change from pre- to postoperative serum levels of VEGF and HER2 ECD did not predict disease-free survival (DFS). A decrease after surgery of EGFR ECD correlated with a statistically significant lower DFS; each 1 ng/ml decrease in EGFR ECD serum level was associated with an increase of event risk of 15% on multivariable analysis (hazard ratio 1.15 95% confidence interval 1.04.-1.28, p=0.006). CONCLUSION: The perioperative absolute change of EGFR ECD significantly correlated with disease outcome of patients with early breast cancer. No correlation was found between preoperative and perioperative absolute change of serum VEGF and HER2 ECD.